NASDAQ
BridgeBio Oncology Therapeutics Inc. (BBOT) has a fcf yield of -29.36% as of Tuesday, August 4, 2026. This represents a 359.09% decrease compared to its 12-month average of -6.40%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.